Amgen (AMGN): FY25 Q3 earnings call, Nov 4, 2025
No Kalshi or Polymarket word markets were listed for Amgen’s Nov 4, 2025 earnings call (FY25 Q3). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
2 matches for “ESMO”; 2 quoted, at least 25 words apart.
…this dramatic 303 study presented at World Lung as well as at ESMO for really meaningful activity in frontline in Phase III. And this is…
…So it's a medicine that we're excited about. I think somebody at ESMO described it as wow squared. So stay tuned. A lot of --…
Agents: this page as TSV at /api/v1/appearances/amgen:2025-11-04:earnings_call · words: /api/v1/brief?appearance=amgen:2025-11-04:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP